AKT1 and lung carcinoma: Conversely, Hsp90aa1 is overexpressed in patients with lung cancer, and downregulation of Hsp90aa1 promotes cell apoptosis and inhibits proliferative ability by inhibiting the AKT1/ERK pathway [29].